Table 1 Demographic and disease characteristics of patients with CVS based on disease onset
Variables | Pediatric Onset (n-29), | Adult Onset (n-72) | p-value |
|---|---|---|---|
Mean age at onset of symptoms(years) | 13.4±12.5 | 32.3±12.3 | 0.0001 |
Female sex | 25 (86%) | 41 (57%) | 0.005 |
Race (%) | |||
White | 25 (86%) | 54 (75%) | 0.29 |
Black | 3 (10%) | 14 (20%) | 0.38 |
Hispanic | 1 (4%) | 2 (3%) | 1 |
Other | 0 | 1 (1%) | |
Type of CVS | |||
CVS plus (%) | 4 (14%) | 2 (3%) | 0.05 |
Catamenial CVS | 5 (17%) | 5 (7%) | 0.15 |
Sato’s CVS | 2 (7%) | 4 (6%) | 1 |
Delay in diagnosis (months) | 124.75±85.86 | 63.53±85.23 | 0.001 |
Coalescence | 14 (48%) | 25 (36%) | 0.25 |
Associated Symptoms | Available n = 27 | Available n = 67 | |
Abdominal Pain | 16 (59%) | 47 (70%) | 0.34 |
Co-morbid disorders | Available n = 28 | Available n = 68 | |
IBS | 9 (32%) | 18 (27%) | 0.62 |
Anxiety | 13 (46%) | 32 (47%) | 0.19 |
Depression | 9 (32%) | 33 (49%) | 0.18 |
Bipolar Disorder | 1 (4%) | 1 (2%) | 0.5 |
Migraine | 16 (55%) | 30 (43%) | 0.28 |
Cholecystectomy | 9 (32%) | 19 (30%) | 0.81 |
Family History (%) | Available n = 25 | Available n = 64 | |
Family history of migraine | 16 (64%) | 41 (64%) | 1 |
Drug use % | Available n = 27 | Available n = 65 | |
Marijuana | 8 (30%) | 27 (42%) | 0.35 |
Alcohol | 7 (26%) | 10 (15%) | 0.25 |
Tobacco | 3 (12%) | 30 (46%) | 0.001 |
Narcotics | 0 | 15 (23%) | 0.004 |
Response to therapy | 19/20 (95%) | 47/56 (84%) | 0.27 |